Bessemer Venture Partners (BVP) is an American venture capital and private equity firm headquartered in San Francisco. It was founded in 1911 and has since grown to manage a significant amount of assets under management, investing in venture capital deals, publicly traded securities, and real estate.

Bessemer Venture Partners helps entrepreneurs lay strong foundations to build and forge long-standing companies. With more than 135 IPOs and 200 portfolio companies in the enterprise, consumer, and healthcare spaces, Bessemer supports founders and CEOs from their early days through every stage of growth. Bessemer’s global portfolio has included Pinterest, Shopify, Twilio, Yelp, LinkedIn, PagerDuty, DocuSign, Wix, Fiverr, and Toast, and has $20 billion of assets under management. Bessemer has teams of investors and partners located in Tel Aviv, Silicon Valley, San Francisco, New York, London, Hong Kong, Boston, and Bangalore. Born from innovations in steel more than a century ago, Bessemer’s storied history has afforded its partners the opportunity to celebrate and scrutinize its best investment decisions (see Memos) and also learn from its mistakes (see Anti-Portfolio).

Life360

MediBuddy

BigBasket

Blue Apron

Boxed

Cornerstone OnDemand

Dynamic Yield

Tile

Rocket Money

Twilio

Twitch

Rigetti Computing

Rocket Lab

SendGrid

Otonomo

PagerDuty

Pinterest

Pipedrive

Zopper

Auth0

Gainsight

Bright Health Group

Mindbody Business

Finmark

Fiverr

Shopify

Procore

Illusive

Instructure

Bessemer Venture Partners

New year, new cloud metric ✨

𝗧𝗵𝗲 𝗥𝘂𝗹𝗲 𝗼𝗳 𝗫 = (𝗚𝗿𝗼𝘄𝘁𝗵 𝗥𝗮𝘁𝗲 𝘅 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝗶𝗲𝗿*) + 𝗙𝗖𝗙 𝗺𝗮𝗿𝗴𝗶𝗻

Our advice to founders CEOs, and CFOs — as you do your own financial business planning for the future, it’s critical that you keep a growth mindset and the proper math in mind, to ensure that you’re maximizing the value potential of your business. 

Here Byron Deeter and Samuel Bondy further explain why leaders need to optimize for growth—at appropriate costs!

https://lnkd.in/gn2GqsGS

* = multiplier on growth rate which today is ~2x for private companies and ~2-3x for public companies

H/T 🫡 The research behind this new metric would not have been possible without the collective thinking and contributions from our Bessemer partnership and team. Special recognition goes out to Kent Bennett, David Cowan, Sameer Dholakia, Mary D'Onofrio, Michael Droesch, Jeff Epstein, Brian Feinstein, Adam Fisher, Talia Goldberg, Elliott Robinson, Janelle Teng, Hansae Catlett, Caty Rea, Grace Ma, Alex Yuditski, among others.

What's on the horizon for the health tech industry? To a room of early stage investors, Sofia Guerra explained the sector's recent performance and how its next cohort of growing private companies can deliver long-term value. 

𝗧𝗵𝗲 𝗺𝗼𝘀𝘁 𝗲𝗻𝗱𝘂𝗿𝗶𝗻𝗴 𝗵𝗲𝗮𝗹𝘁𝗵 𝘁𝗲𝗰𝗵 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗼𝗳 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄 𝘄𝗶𝗹𝗹 𝗵𝗮𝘃𝗲 𝘁𝗵𝗲 "𝗮𝗻𝗮𝘁𝗼𝗺𝘆 𝗼𝗳 𝘁𝗵𝗲 𝗽𝗵𝗼𝗲𝗻𝗶𝘅" 𝗮𝗻𝗱 𝘀𝗵𝗮𝗿𝗲 𝗳𝗶𝘃𝗲 𝗺𝗮𝗷𝗼𝗿 𝗰𝗵𝗮𝗿𝗮𝗰𝘁𝗲𝗿𝗶𝘀𝘁𝗶𝗰𝘀 𝗶𝗻 𝗰𝗼𝗺𝗺𝗼𝗻: 

🔥 𝗛𝗮𝗶𝗿 𝗼𝗻 𝗳𝗶𝗿𝗲 𝗽𝗿𝗼𝗯𝗹𝗲𝗺: Solve a mission-critical problem for your customer. 

🏥 𝗛𝗮𝗿𝗱 𝗥𝗢𝗜 𝗮𝗻𝗱 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀: Demonstrate clear and fast return on investment for your customer.

📈 𝗟𝗮𝗿𝗴𝗲 𝗮𝗻𝗱 𝗴𝗿𝗼𝘄𝗶𝗻𝗴 𝗺𝗮𝗿𝗸𝗲𝘁: Take advantage of tailwinds and systemic shifts for adoption and regulation to articulate a strong ‘why now’ for your opportunity.

💰 𝗔𝘁𝘁𝗿𝗮𝗰𝘁𝗶𝘃𝗲 𝘂𝗻𝗶𝘁 𝗲𝗰𝗼𝗻𝗼𝗺𝗶𝗰𝘀: Focus on high margins and recurring revenues, which are strong signs of attractive and enduring business models.

🧠 𝗦𝘁𝗿𝗼𝗻𝗴 𝗺𝘂𝗹𝘁𝗶-𝗱𝗶𝘀𝗰𝗶𝗽𝗹𝗶𝗻𝗮𝗿𝘆 𝘁𝗲𝗮𝗺𝘀: Build a team that marries industry and technical knowledge to accelerate distribution, and build best-in-class product. 

Read and watch the full report ⤵️ 

https://lnkd.in/g8EfDQbC

#healthcare #healthtech #startups #venturecapital

There are few leaders quite like Jeff Lawson, co-founder of Twilio. He’s had a legendary 15-year journey as CEO, leaving an indelible mark on the cloud economy because of his business leadership and innovation, and we wish him well on his next adventure. ☁️

From the Atlas archives, we pulled out Byron Deeter and Jeff's episode on Cloud Giants from 2021. Together, they explored Jeff's journey as an entrepreneur, how he scaled Twilio to IPO and beyond, and the hard-earned lessons every founder needs to internalize:

1️⃣ Entrepreneurship is a series of setbacks, problem solving, and finding your purpose.
2️⃣ Internal tools are the inspiration for many billion-dollar SaaS businesses.
3️⃣ To build a world-class product, ruthlessly remove friction and barriers to experimentation, and don't forget revenue is the best funding there is to build new products.
4️⃣ Creating a meaningful place to work means your product contributes back to society.
 
Read and listen to the full conversation — https://lnkd.in/eAtC-9YJ

🩺 Introducing Bessemer’s 2024 Healthcare and Life Sciences Predictions.

As long-awaited IPOs, new opportunities from AI, and regulatory tailwinds stimulate health tech and biotech in 2024, we believe the sector remains highly attractive. So, what’s in store for the year ahead?
 
✔️ Open-source AI models.
✔️ Value-based care (VBC) shifts.
✔️ Longevity medicine.
✔️ And more.

Read our 🔟 predictions, plus additional ones from leaders in our portfolio, on Atlas today: https://lnkd.in/g3qTZp-T

The only app I’ve ever added to my iPhone dock is Perplexity. It has become my gateway to information and the web. 

We Bessemer Venture Partners are thrilled to officially be a part of the Perplexity journey! 

I have gotten to know the team over the past year. What stands out the most is their speed. They are relentless shipping  machines. (And hiring! Please dm).

Innovation happens slowly, and then all at once. But great transformation is never without a strong foundation of patience, fortitude, and audacious optimism. 

𝟮𝟬𝟮𝟯 was the year we crossed The Rubicon of Artificial Intelligence. 

𝟮𝟬𝟮𝟯 was the year we supported teams through tough economic times and weathered a year of global tumult. 

And 𝟮𝟬𝟮𝟯 was the year we also learned that community is necessary for progress.

Looking forward, we’re excited to continue to back founders who demonstrate resilience and determination to build, sustain, and grow their businesses through market cycles and technological paradigm shifts. 

Dive into our year in review. 💫

https://lnkd.in/g6SwPuRX

We're introducing a new metric — 𝗧𝗵𝗲 𝗥𝘂𝗹𝗲 𝗼𝗳 𝗫. 

Why?

Assigning equal weight to growth and profitability for late-stage businesses is flawed and has caused misguided business decisions. It's about time executives of both private and public cloud companies have a new metric that more accurately represents a cloud business’s valuation by placing a more accurate weight on its growth and future recurring revenue.

While the focus on efficiency is well-founded, the traditional 𝗥𝘂𝗹𝗲 𝗼𝗳 𝟰𝟬 math is dead wrong as you approach breakeven and turn free cash flow positive. 

Dive into Byron Deeter and Samuel Bondy's latest on TechCrunch explaining the Rule of X, the analysis and fundamentals of our thinking, and why leaders need to optimize for growth—at appropriate costs! 

https://lnkd.in/gePbNUT6

Introducing the Rule of X! Finance execs love the Rule of 40 for its simplicity, but for many efficient cloud companies, assigning equal weight to growth and profitability is flawed. This has caused many misguided business decisions. Our take? Even in tight markets, growth should be valued at least 2-3x more than FCF margin. At Bessemer Venture Partners, we wanted to introduce a new metric that more accurately weighs the tradeoff – the Rule of X. 

See more here: https://lnkd.in/dsheHPnN

And we're live! The full conversation, "Building the Next Generation of AI Companies" at last week's Forbes Healthcare Summit, check out the video below:

https://lnkd.in/edYcJH-V

Bessemer Venture Partners Vineeta Agarwala, MD PhD a16z Bio + Health Daphne Koller insitro Shivdev Rao Abridge #healthcare #lifesciences #biotech #artificialintelligence #ai #generativeai #forbes #forbeshealth

Thanks to Bloomberg News for having me on to discuss the potential of health AI as well as how some of Bessemer Venture Partners portfolio companies - Headspace and Hinge Health -  are forging the future for how healthcare is delivered across the globe.

COM:BVP

Bessemer Venture Partners

Analysis Not Available